TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug
TargED Biopharmaceuticals, a biotech spin-
“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook
Sirius Medical is proud to announce the first clinical results and global commercial implants of the Sirius Pintuition system.
The first clinical safety and performance study shows that Sirius Pintuition System is safe and performs as intended for breast cance
Merely a couple of weeks after the Finals of the Venture Challenge summer Edition, six new teams started their Venture Challenge adventure in the Fall 2020 edition with their first bootcamp at Pivot Park.
Designation granted for the treatment of MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes) syndrome.
Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial dise
On September 18 the participants of the Venture Challenge Summer 2020 presented the result of their efforts to the Venture Challenge jury consisting of Carine van den Brink, Geert-Jan Mulder, Eline Vrijland-van Beest, André van de Sande and Kim Lucassen in t